본문 바로가기
KERD
논문KCI 등재

LPS로 유도된 염증모델에 대한 청포축어탕의 억제 효과

Inhibitory Effects of Cheongpochukeo-tang on LPS-induced Inflammation Model

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류한의학

초록

Objective: This study was performed to investigate the inhibitory effect of Cheongpochukeo-tang (CCT) on lipopolysaccharide (LPS)-induced inflammation model. Methods: RAW 264.7 cells were pre-treated with CCT and incubated with LPS (500 ng/ml) after 1 hour. Cell viability was measured by MTT assay to figure out cytotoxicity of CCT. The production of nitric oxide and mRNA expression of pro-inflammatory cytokine were measured. And the activation of mitogen-activated protein kinases (MAPKs) and nuclear factor kappa B (NF-κB) were examined to figure out molecular mechanisms of CCT’s anti-inflammatory effects. In addition, mice survival rate and cytokine levels of serum were observed after treated with CCT. And mice liver tissues were observed and their cytokines levels in liver tissue were measured. Results: CCT did not have cytotoxic effect in RAW 264.7 cells. It inhibited LPS-induced nitric oxide (NO) production, but showed an increase in NO by itself at 2 mg/ml concentration. CCT inhibited mRNA expression of IL-1β, IL-6, TNF-α in a dose dependant and the activaton of MAPKs and NF-κB. In addition, CCT reduced mortality in the LPS-induced mouse model and inhibited production of cytokines in mouse serum and liver tissue. Conclusion: The results suggest that CCT could reduce LPS-induced inflammation by inhibiting MAPKs and NF-κB activaton, NO production, and pro-inflammatory cytokines secretion. Thereby, CCT could be effective medicine for the inflammatory disease.

Abstract

Objective: This study was performed to investigate the inhibitory effect of Cheongpochukeo-tang (CCT) on lipopolysaccharide (LPS)-induced inflammation model. Methods: RAW 264.7 cells were pre-treated with CCT and incubated with LPS (500 ng/ml) after 1 hour. Cell viability was measured by MTT assay to figure out cytotoxicity of CCT. The production of nitric oxide and mRNA expression of pro-inflammatory cytokine were measured. And the activation of mitogen-activated protein kinases (MAPKs) and nuclear factor kappa B (NF-κB) were examined to figure out molecular mechanisms of CCT’s anti-inflammatory effects. In addition, mice survival rate and cytokine levels of serum were observed after treated with CCT. And mice liver tissues were observed and their cytokines levels in liver tissue were measured. Results: CCT did not have cytotoxic effect in RAW 264.7 cells. It inhibited LPS-induced nitric oxide (NO) production, but showed an increase in NO by itself at 2 mg/ml concentration. CCT inhibited mRNA expression of IL-1β, IL-6, TNF-α in a dose dependant and the activaton of MAPKs and NF-κB. In addition, CCT reduced mortality in the LPS-induced mouse model and inhibited production of cytokines in mouse serum and liver tissue. Conclusion: The results suggest that CCT could reduce LPS-induced inflammation by inhibiting MAPKs and NF-κB activaton, NO production, and pro-inflammatory cytokines secretion. Thereby, CCT could be effective medicine for the inflammatory disease.

참고문헌 (54)

  1. Kumar V, "Robbins basic pathology", pp.31~35 (2009), Epublic
  2. Male D, "Immunology", pp.61~69 (1998), Mosby
  3. Korean Society of Obstetrics and Gynecology, "Gynecology", pp.154~ (2015), Korea Medical Book Publishing Company
  4. The society of Korean medicine obstetrics and gynecology, "Korean medicine obstetrics and gynecology", pp.164~ (2016), Euiseongdang
  5. Tsevat DG, "Sexually transmitted diseases and infertility", American journal of obstetrics and gynecology, 216(1), pp.1~9 (2017)
  6. Kyunghee university Korean medicine hospital, "Hanbangjejehaeseoljip(韓方製劑解說集(全))", pp.134~ (1983), Kyunghee university medicine center
  7. Gang SH, "Experimental studies on effects of Qingbaozhuyutang (淸胞逐瘀湯), bee veenom on the blood stasis pattern", The journal of Korean oriental medicine society, 16(1), pp.351~369 (1995)
  8. Lee KS, "Clinical observation on Cheongpochookeo-tang", The Journal Of Oriental Obstetrics & Gynecology, 1(1), pp.33~37 (1987)
  9. 위효선, "자궁내막증으로 인한 복강 내 유착으로 체외수정시술 권고 받은 후 한방 치료로 임신된 난임 환자의 증례 보고", 대한한방부인과학회지, 23(3), pp.213~220 (2010), 대한한방부인과학회
  10. 조성희, "慢性骨盤炎을 韓方治療한 治驗一例 ( 韓藥內服藥과 保留灌腸治療 중심으로 )", 대한한방부인과학회지, 15(3), pp.181~189 (2002), 대한한방부인과학회
  11. 반혜란, "만성골반염에 대한 임상 1례 보고", 대한한방부인과학회지, 18(1), pp.253~261 (2005), 대한한방부인과학회
  12. 손지혜, "골반염 환자에 대한 한방치료 치험 1례", 대한한방부인과학회지, 27(3), pp.158~167 (2014), 대한한방부인과학회[DOI]
  13. Chung JH, "Effects of Kyǒkhach’ugotang and Ch’ǒnp’och’ugotang on anti-inflammatory, antipyretic, analgesic, anti-microbial and anti-thrombose action", Kyunghee Univ. Theses collection, 15, pp.101~116 (1986)
  14. Kim DH, "Rubi Fructus Water Extract Alleviates LPS-Stimulated Macrophage Activation via an ER Stress-Induced Calcium", CHOP Signaling Pathway, 2020, pp.12(11), 3577~
  15. Wu C, "Neocryptotanshinone inhibits lipopolysaccharide-induced inflammation in RAW264.7 macrophages by suppression of NF-κB and iNOS signaling pathways", Acta Pharmaceutica Sinica B, 5(4), pp.323~329 (2015)
  16. Kim YH, "Biological Properties of Vibrio vulnificus Lipopolysaccharide and compared to those of Escherichia coli and Salmonella typhimurium Lipopolysaccharides", Korean journal of microbiology, 27(2), pp.147~154 (1989)
  17. Tateda K, "Lipopolysaccharideinduced lethality and cytokine production in aged mice", Infect Immun, 64(3), pp.769~774 (1996)
  18. Patel S, "RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases", Cell Death &Differentiation, 27(1), pp.161~175 (2020)
  19. Yun YG, "onguibangje and Cheobanghaeseol (東醫方劑와 處方解說)", pp.288~289 (2011), Euiseongdang
  20. 윤혜진, "薏苡仁의 염증성 사이토카인 발현 및 조절에 관한 연구", 대한한방소아과학회지, 23(1), pp.159~171 (2009), 대한한방소아과학회
  21. 류익한, "敗醬 물 추출물의 LPS로 유도된 RAW 264.7 세포와 mouse 염증모델에서 cytokine 및 NF-κB의 활성에 미치는 효과", 대한한방부인과학회지, 30(2), pp.1~15 (2017), 대한한방부인과학회[DOI]
  22. Lee EJ, "Inhibition of LPS-induced inflammatory biomarkers by ethyl acetate fraction of Patrinia scabiosaefolia through suppression of NF-κB activation in RAW 264.7 cells", Immunopharmacology and Immunotoxicology, 34(2), pp.282~291 (2012)
  23. 김민선, "LPS로 유도한 대식세포의 염증반응에서 우슬의 항염증 효과", 대한본초학회지, 26(2), pp.51~57 (2011), 대한본초학회
  24. Chung WS, "The anti-inflammatory effects of Achyranthes japonica", Department of Medicine, pp.2011
  25. 이동언, "金銀花 및 金銀花全草가 Raw 264.7 cell에서 LPS로 유도된 NO의 생성, iNOS, COX-2 및 cytokine에 미치는 영향", 동의생리병리학회지, 19(2), pp.481~489 (2005), 한의병리학회
  26. 윤용갑, "금은화 수용성 추출물의 LPS 유도 염증매개물 억제 효과", 대한본초학회지, 22(3), pp.117~125 (2007), 대한본초학회
  27. 채기원, "금은화의 항염작용과 파골세포 형성 억제효과", 박사, 본초학, pp.2008
  28. 윤경진, "금은화 추출액이 RAW 264.7 Macrophage에서의 NO와 PGE2 생성에 미치는 영향", Journal of Acupuncture Research, 29(1), pp.67~74 (2012), 대한침구의학회
  29. 류효경, "連翹와 金銀花 에탄올 추출물의 항염증 효능 연구", 대한한방부인과학회지, 33(3), pp.40~59 (2020), 대한한방부인과학회[DOI]
  30. 최창민, "난임 변증진료 현황 및 난임변증설문지 개발에 관한 연구", 대한한방부인과학회지, 29(2), pp.29~46 (2016), 대한한방부인과학회[DOI]
  31. Westrom L, "Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results", Sex Transm Dis, 19(4), pp.185~192 (1992)
  32. Grodstein F, "Relation of tubal infertility to history of sexually transmitted diseases", American journal of epidemiology, 137(5), pp.577~584 (1993)
  33. Research proposal on the clinical cause and support plan of infertility, "Joeng JE", NHIS Ilsan Hospital Institute of Health Insurance & Clinical Research, 51~ (2017)
  34. Tsan MF, "Pathogen-associated molecular pattern contamination as putative endogenous ligands of Toll-like receptors", Journal of endotoxin research, 13(1), pp.6~14 (2007)
  35. Sharma JN, "Role of nitric oxide in inflammatory diseases", Inflammopharmacology, 15(6), pp.252~259 (2007)
  36. Spiller F, "Targeting nitric oxide as a key modulator of sepsis, arthritis and pain", Nitric Oxide, 89(1), pp.32~40 (2019)
  37. Boveris A, "The role of mitochondrial nitric oxide synthase in inflammation and septic shock", Free radical biology and medicine, 33(9), pp.1186~1193 (2002)
  38. Tewari D, "Role of Nitric oxide in neurodegeneration: Function, regulation and inhibition", Curr Neuropharmacol, 18(1), pp.1~13 (2020)
  39. Kishimoto T, "Interleukin-6 family of cytokines and gp130", Blood, 86(4), pp.1243~1254 (1995)
  40. Loeffler S, "Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3and Sp1", International journal of cancer, 115(2), pp.202~213 (2005)
  41. John MAS, "Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma", Archives of Otolaryngology-Head & Neck Surgery, 130(8), pp.929~935 (2004)
  42. Kotowicz B, "The value of tumor marker and cytokine analysis for the assessment of regional lymph node status in cervical cancer patients", International Journal of Gynecologic Cancer, 18(6), pp.1279~1284 (2008)
  43. Jones SA, "Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer", Nature Reviews Immunology, 18(12), pp.773~789 (2018)
  44. Abul K, "Cellular and molecular immunology", pp.84~89 (2013), Panmuneducation
  45. Ren K, "Role of interleukin-1βduring pain and inflammation", Brain research reviews, 60(1), pp.57~64 (2009)
  46. Borrelli E, "Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk", Critical care medicine, 24(3), pp.392~397 (1996)
  47. Ramseyer VD, "Tumor necrosis factor-α : regulation of renal function and blood pressure", American Journal of Physiology-Renal Physiology, 304(10), pp.1231~1242 (2013)
  48. Cobb MH, "Dimerization in MAP-kinase signaling", Trends Biochem Sci, 25(1), pp.7~9 (2000)
  49. Cargnello M, "Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases", Microbiology and molecular biology reviews, 75(1), pp.50~83 (2011)
  50. Lee AK, "Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-alpha and COX-2expression by sauchinone effects on I-kappa B alpha phosphorylation, C", EBP and AP-1 activation, 2003, pp.139(1), 11~12
  51. Baeuerle PA, "I kappa B-NF-kappa B structures: at the interface of inflammation control", Cell, 95(6), pp.729~731 (1998)
  52. 이지은, "약물 전달 시스템-소아내분비 영역과 관련하여", Annals of Pediatric Endocrinology & Metabolism, 16(1), pp.7~12 (2011), 대한소아내분비학회
  53. Turner PV, "Administration of substances to laboratory animals : routes of administration and factors to consider", Journal of the American Association for Laboratory Animal Science, 50(5), pp.600~613 (2011)
  54. Su GL, "Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation", American Journal of Physiology-Gastrointestinal and Liver Physiology, 283(2), pp.256~265 (2002)

관련 논문AI추천

이 간행물의 다른 논문 (11건)